Bone Biologics: Bone Biologics Announces Closing of $2.0 Million Public Offering

(marketscreener.com) Bone Biologics Corporation , a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced public offering of an aggregate of 781,251 shares of its common stock and warrants to purchase up to 781,251 shares of common stock, at a public offering price of $2.56 per share and accompanying...https://www.marketscreener.com/quote/stock/BONE-BIOLOGICS-CORPORATIO-120796041/news/Bone-Biologics-Announces-Closing-of-2-0-Million-Public-Offering-46106601/?utm_medium=RSS&utm_content=20240306